{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:06:50Z","timestamp":1789142810998,"version":"build-2803163510"},"reference-count":118,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82371117"],"award-info":[{"award-number":["82371117"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00011-025-02110-8","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T17:05:55Z","timestamp":1760720755000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["MUC1 in the upper\u2013lower airway inflammatory continuum: an endotype-centered perspective"],"prefix":"10.1007","volume":"74","author":[{"given":"Linghui","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiao Hui","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-Yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"issue":"3","key":"2110_CR1","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.jaip.2020.09.063","volume":"9","author":"TM Laidlaw","year":"2021","unstructured":"Laidlaw TM, et al. Chronic rhinosinusitis with nasal polyps and asthma. J Allergy Clin Immunol Pract. 2021;9(3):1133\u201341. https:\/\/doi.org\/10.1016\/j.jaip.2020.09.063.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"2110_CR2","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.anai.2024.02.008","volume":"132","author":"Y Yao","year":"2024","unstructured":"Yao Y, et al. Proteomic and metabolomic proof of concept for unified airways in chronic rhinosinusitis and asthma. Ann Allergy Asthma Immunol. 2024;132(6):713-722.e4. https:\/\/doi.org\/10.1016\/j.anai.2024.02.008.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"2110_CR3","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/j.1398-9995.2007.01545.x","volume":"63","author":"G Hens","year":"2008","unstructured":"Hens G, et al. Sinonasal pathology in nonallergic asthma and COPD: \u2018united airway disease\u2019 beyond the scope of allergy. Allergy. 2008;63(3):261\u20137. https:\/\/doi.org\/10.1111\/j.1398-9995.2007.01545.x.","journal-title":"Allergy"},{"key":"2110_CR4","doi-asserted-by":"publisher","first-page":"655","DOI":"10.2147\/copd.S124248","volume":"12","author":"X Yang","year":"2017","unstructured":"Yang X, et al. Chronic rhinosinusitis is associated with higher prevalence and severity of bronchiectasis in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:655\u201362. https:\/\/doi.org\/10.2147\/copd.S124248.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2110_CR5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13601-020-00332-z","volume":"10","author":"M Wang","year":"2020","unstructured":"Wang M, et al. Distinct type 2-high inflammation associated molecular signatures of chronic rhinosinusitis with nasal polyps with comorbid asthma. Clin Transl Allergy. 2020;10:26. https:\/\/doi.org\/10.1186\/s13601-020-00332-z.","journal-title":"Clin Transl Allergy"},{"issue":"9","key":"2110_CR6","doi-asserted-by":"publisher","first-page":"Jc102","DOI":"10.7326\/j23-0063","volume":"176","author":"RA Estrada","year":"2023","unstructured":"Estrada RA, Maselli DJ, Anzueto AR. In COPD with type 2 inflammation despite inhaled triple therapy, dupilumab safely reduced exacerbations. Ann Intern Med. 2023;176(9):Jc102. https:\/\/doi.org\/10.7326\/j23-0063.","journal-title":"Ann Intern Med"},{"issue":"9","key":"2110_CR7","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1093\/carcin\/bgaa082","volume":"41","author":"DW Kufe","year":"2020","unstructured":"Kufe DW. MUC1-C in chronic inflammation and carcinogenesis; emergence as a target for cancer treatment. Carcinogenesis. 2020;41(9):1173\u201383. https:\/\/doi.org\/10.1093\/carcin\/bgaa082.","journal-title":"Carcinogenesis"},{"issue":"1","key":"2110_CR8","doi-asserted-by":"publisher","first-page":"2313671","DOI":"10.1080\/07853890.2024.2313671","volume":"56","author":"H Xu","year":"2024","unstructured":"Xu H, et al. MUC1-EGFR crosstalk with IL-6 by activating NF-\u03baB and MAPK pathways to regulate the stemness and paclitaxel-resistance of lung adenocarcinoma. Ann Med. 2024;56(1):2313671. https:\/\/doi.org\/10.1080\/07853890.2024.2313671.","journal-title":"Ann Med"},{"key":"2110_CR9","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.2147\/dddt.S222296","volume":"13","author":"YM Wang","year":"2019","unstructured":"Wang YM, et al. Paclitaxel alleviated sepsis-induced acute lung injury by activating MUC1 and suppressing TLR-4\/NF-\u03baB pathway. Drug Des Dev Ther. 2019;13:3391\u2013404. https:\/\/doi.org\/10.2147\/dddt.S222296.","journal-title":"Drug Des Dev Ther"},{"issue":"160","key":"2110_CR10","doi-asserted-by":"publisher","first-page":"ra9","DOI":"10.1126\/scisignal.2001426","volume":"4","author":"R Ahmad","year":"2011","unstructured":"Ahmad R, et al. MUC1-C oncoprotein promotes STAT3 activation in an autoinductive regulatory loop. Sci Signal. 2011;4(160):ra9. https:\/\/doi.org\/10.1126\/scisignal.2001426.","journal-title":"Sci Signal"},{"issue":"1","key":"2110_CR11","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s40659-023-00460-3","volume":"56","author":"SS Cui","year":"2023","unstructured":"Cui SS, et al. Mucin1 induced trophoblast dysfunction in gestational diabetes mellitus via Wnt\/\u03b2-catenin pathway. Biol Res. 2023;56(1):48. https:\/\/doi.org\/10.1186\/s40659-023-00460-3.","journal-title":"Biol Res"},{"issue":"4","key":"2110_CR12","doi-asserted-by":"publisher","first-page":"e0105522","DOI":"10.1128\/mbio.01055-22","volume":"13","author":"E Iverson","year":"2022","unstructured":"Iverson E, et al. Membrane-tethered mucin 1 is stimulated by interferon and virus infection in multiple cell types and inhibits influenza A virus infection in human airway epithelium. MBio. 2022;13(4):e0105522. https:\/\/doi.org\/10.1128\/mbio.01055-22.","journal-title":"MBio"},{"issue":"1","key":"2110_CR13","doi-asserted-by":"publisher","first-page":"22725","DOI":"10.1038\/s41598-021-02242-x","volume":"11","author":"AC Verceles","year":"2021","unstructured":"Verceles AC, et al. MUC1 ectodomain is a flagellin-targeting decoy receptor and biomarker operative during Pseudomonas aeruginosa lung infection. Sci Rep. 2021;11(1):22725. https:\/\/doi.org\/10.1038\/s41598-021-02242-x.","journal-title":"Sci Rep"},{"issue":"1","key":"2110_CR14","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s12931-023-02550-y","volume":"24","author":"L Liu","year":"2023","unstructured":"Liu L, et al. MUC1 attenuates neutrophilic airway inflammation in asthma by reducing NLRP3 inflammasome-mediated pyroptosis through the inhibition of the TLR4\/MyD88\/NF-\u03baB pathway. Respir Res. 2023;24(1):255. https:\/\/doi.org\/10.1186\/s12931-023-02550-y.","journal-title":"Respir Res"},{"key":"2110_CR15","doi-asserted-by":"publisher","first-page":"745233","DOI":"10.3389\/fimmu.2021.745233","volume":"12","author":"T Zhang","year":"2021","unstructured":"Zhang T, et al. KL-6 as an immunological biomarker predicts the severity, progression, acute exacerbation, and poor outcomes of interstitial lung disease: a systematic review and meta-analysis. Front Immunol. 2021;12:745233. https:\/\/doi.org\/10.3389\/fimmu.2021.745233.","journal-title":"Front Immunol"},{"key":"2110_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13040689","author":"M d'Alessandro","year":"2021","unstructured":"d\u2019Alessandro M, et al. Serum concentrations of KL-6 in patients with IPF and lung cancer and serial measurements of KL-6 in IPF patients treated with antifibrotic therapy. Cancers. 2021. https:\/\/doi.org\/10.3390\/cancers13040689.","journal-title":"Cancers"},{"issue":"1","key":"2110_CR17","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12931-020-01560-4","volume":"21","author":"AN Frix","year":"2020","unstructured":"Frix AN, et al. Could KL-6 levels in COVID-19 help to predict lung disease? Respir Res. 2020;21(1):309. https:\/\/doi.org\/10.1186\/s12931-020-01560-4.","journal-title":"Respir Res"},{"issue":"2","key":"2110_CR18","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.bbrc.2017.08.056","volume":"492","author":"K Kato","year":"2017","unstructured":"Kato K, et al. Pseudomonas aeruginosa increases MUC1 expression in macrophages through the TLR4-p38 pathway. Biochem Biophys Res Commun. 2017;492(2):231\u20135. https:\/\/doi.org\/10.1016\/j.bbrc.2017.08.056.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"2110_CR19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/all.13546","volume":"74","author":"J Milara","year":"2019","unstructured":"Milara J, et al. Mucin 1 deficiency mediates corticosteroid insensitivity in asthma. Allergy. 2019;74(1):111\u201321. https:\/\/doi.org\/10.1111\/all.13546.","journal-title":"Allergy"},{"issue":"4","key":"2110_CR20","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1053\/j.gastro.2011.12.036","volume":"142","author":"A Nishida","year":"2012","unstructured":"Nishida A, et al. The membrane-bound mucin Muc1 regulates T helper 17-cell responses and colitis in mice. Gastroenterology. 2012;142(4):865\u201374. https:\/\/doi.org\/10.1053\/j.gastro.2011.12.036.","journal-title":"Gastroenterology"},{"issue":"3","key":"2110_CR21","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00408-024-00702-5","volume":"202","author":"Y Wang","year":"2024","unstructured":"Wang Y, et al. Associations of the serum KL-6 with severity and prognosis in patients with acute exacerbation of chronic obstructive pulmonary disease. Lung. 2024;202(3):245\u201355. https:\/\/doi.org\/10.1007\/s00408-024-00702-5.","journal-title":"Lung"},{"issue":"10","key":"2110_CR22","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1042\/cs20191085","volume":"134","author":"M Padra","year":"2020","unstructured":"Padra M, et al. Increased MUC1 plus a larger quantity and complex size for MUC5AC in the peripheral airway lumen of long-term tobacco smokers. Clin Sci. 2020;134(10):1107\u201325. https:\/\/doi.org\/10.1042\/cs20191085.","journal-title":"Clin Sci"},{"key":"2110_CR23","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0149-2020","author":"B Ballester","year":"2021","unstructured":"Ballester B, Milara J, Cortijo J. The role of mucin 1 in respiratory diseases. Eur Respir Rev. 2021. https:\/\/doi.org\/10.1183\/16000617.0149-2020.","journal-title":"Eur Respir Rev"},{"key":"2110_CR24","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3389\/fcimb.2019.00117","volume":"9","author":"P Dhar","year":"2019","unstructured":"Dhar P, McAuley J. The role of the cell surface mucin MUC1 as a barrier to infection and regulator of inflammation. Front Cell Infect Microbiol. 2019;9:117. https:\/\/doi.org\/10.3389\/fcimb.2019.00117.","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"2110_CR25","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1159\/000254790","volume":"2","author":"MA Williams","year":"2010","unstructured":"Williams MA, et al. Deletion of the mucin-like molecule muc1 enhances dendritic cell activation in response to toll-like receptor ligands. J Innate Immun. 2010;2(2):123\u201343. https:\/\/doi.org\/10.1159\/000254790.","journal-title":"J Innate Immun"},{"issue":"2","key":"2110_CR26","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1165\/rcmb.2009-0323OC","volume":"44","author":"S Choi","year":"2011","unstructured":"Choi S, et al. TNF-\u03b1 is a key regulator of MUC1, an anti-inflammatory molecule, during airway Pseudomonas aeruginosa infection. Am J Respir Cell Mol Biol. 2011;44(2):255\u201360. https:\/\/doi.org\/10.1165\/rcmb.2009-0323OC.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"3","key":"2110_CR27","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00011-015-0908-8","volume":"65","author":"K Kato","year":"2016","unstructured":"Kato K, Lillehoj EP, Kim KC. Pseudomonas aeruginosa stimulates tyrosine phosphorylation of and TLR5 association with the MUC1 cytoplasmic tail through EGFR activation. Inflamm Res. 2016;65(3):225\u201333. https:\/\/doi.org\/10.1007\/s00011-015-0908-8.","journal-title":"Inflamm Res"},{"issue":"4","key":"2110_CR28","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.4049\/jimmunol.1102405","volume":"188","author":"K Kato","year":"2012","unstructured":"Kato K, et al. Membrane-tethered MUC1 mucin is phosphorylated by epidermal growth factor receptor in airway epithelial cells and associates with TLR5 to inhibit recruitment of MyD88. J Immunol. 2012;188(4):2014\u201322. https:\/\/doi.org\/10.4049\/jimmunol.1102405.","journal-title":"J Immunol"},{"issue":"2","key":"2110_CR29","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1074\/jbc.RA118.006022","volume":"294","author":"EP Lillehoj","year":"2019","unstructured":"Lillehoj EP, et al. Neuraminidase 1-mediated desialylation of the mucin 1 ectodomain releases a decoy receptor that protects against Pseudomonas aeruginosa lung infection. J Biol Chem. 2019;294(2):662\u201378. https:\/\/doi.org\/10.1074\/jbc.RA118.006022.","journal-title":"J Biol Chem"},{"issue":"2","key":"2110_CR30","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1165\/rcmb.2011-0142OC","volume":"46","author":"Y Kyo","year":"2012","unstructured":"Kyo Y, et al. Antiinflammatory role of MUC1 mucin during infection with nontypeable Haemophilus influenzae. Am J Respir Cell Mol Biol. 2012;46(2):149\u201356. https:\/\/doi.org\/10.1165\/rcmb.2011-0142OC.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"3","key":"2110_CR31","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/gene.2016.10","volume":"17","author":"GZ Ng","year":"2016","unstructured":"Ng GZ, Sutton P. The MUC1 mucin specifically inhibits activation of the NLRP3 inflammasome. Genes Immun. 2016;17(3):203\u20136. https:\/\/doi.org\/10.1038\/gene.2016.10.","journal-title":"Genes Immun"},{"issue":"8","key":"2110_CR32","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1080\/21505594.2017.1341021","volume":"8","author":"P Dhar","year":"2017","unstructured":"Dhar P, et al. Mucin 1 protects against severe Streptococcus pneumoniae infection. Virulence. 2017;8(8):1631\u201342. https:\/\/doi.org\/10.1080\/21505594.2017.1341021.","journal-title":"Virulence"},{"key":"2110_CR33","doi-asserted-by":"publisher","first-page":"1284148","DOI":"10.3389\/fimmu.2023.1284148","volume":"14","author":"BJA Silva","year":"2023","unstructured":"Silva BJA, et al. IFN-\u03b3-mediated control of SARS-CoV-2 infection through nitric oxide. Front Immunol. 2023;14:1284148. https:\/\/doi.org\/10.3389\/fimmu.2023.1284148.","journal-title":"Front Immunol"},{"key":"2110_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8020177","author":"LM Stephens","year":"2020","unstructured":"Stephens LM, Varga SM. Function and modulation of type I interferons during respiratory syncytial virus infection. Vaccines. 2020. https:\/\/doi.org\/10.3390\/vaccines8020177.","journal-title":"Vaccines"},{"issue":"5","key":"2110_CR35","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1002\/jcb.21539","volume":"102","author":"G Theodoropoulos","year":"2007","unstructured":"Theodoropoulos G, Carraway KL. Molecular signaling in the regulation of mucins. J Cell Biochem. 2007;102(5):1103\u201316. https:\/\/doi.org\/10.1002\/jcb.21539.","journal-title":"J Cell Biochem"},{"issue":"3","key":"2110_CR36","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1165\/rcmb.2014-0018OC","volume":"51","author":"K Kato","year":"2014","unstructured":"Kato K, Lillehoj EP, Kim KC. MUC1 regulates epithelial inflammation and apoptosis by PolyI:C through inhibition of Toll\/IL-1 receptor-domain-containing adapter-inducing IFN-\u03b2 (TRIF) recruitment to Toll-like receptor 3. Am J Respir Cell Mol Biol. 2014;51(3):446\u201354. https:\/\/doi.org\/10.1165\/rcmb.2014-0018OC.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"4","key":"2110_CR37","doi-asserted-by":"publisher","first-page":"L558","DOI":"10.1152\/ajplung.00225.2009","volume":"298","author":"Y Li","year":"2010","unstructured":"Li Y, et al. Anti-inflammatory effect of MUC1 during respiratory syncytial virus infection of lung epithelial cells in vitro. Am J Physiol Lung Cell Mol Physiol. 2010;298(4):L558\u201363. https:\/\/doi.org\/10.1152\/ajplung.00225.2009.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"2110_CR38","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1186\/s12879-023-08837-1","volume":"23","author":"Y Jin","year":"2023","unstructured":"Jin Y, et al. Role of the cAMP-PKA-NF-\u03baB pathway in Mucin1 over-expression in A549 cells during respiratory syncytial virus infection. BMC Infect Dis. 2023;23(1):845. https:\/\/doi.org\/10.1186\/s12879-023-08837-1.","journal-title":"BMC Infect Dis"},{"key":"2110_CR39","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02374-20","author":"M Chatterjee","year":"2020","unstructured":"Chatterjee M, van Putten JPM, Strijbis K. Defensive properties of mucin glycoproteins during respiratory infections-relevance for SARS-CoV-2. MBio. 2020. https:\/\/doi.org\/10.1128\/mBio.02374-20.","journal-title":"MBio"},{"issue":"6","key":"2110_CR40","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1038\/mi.2017.16","volume":"10","author":"JL McAuley","year":"2017","unstructured":"McAuley JL, et al. The cell surface mucin MUC1 limits the severity of influenza A virus infection. Mucosal Immunol. 2017;10(6):1581\u201393. https:\/\/doi.org\/10.1038\/mi.2017.16.","journal-title":"Mucosal Immunol"},{"issue":"1","key":"2110_CR41","doi-asserted-by":"publisher","first-page":"6198","DOI":"10.1038\/s41467-023-41912-4","volume":"14","author":"T Nakanishi","year":"2023","unstructured":"Nakanishi T, et al. Alternative splicing in lung influences COVID-19 severity and respiratory diseases. Nat Commun. 2023;14(1):6198. https:\/\/doi.org\/10.1038\/s41467-023-41912-4.","journal-title":"Nat Commun"},{"key":"2110_CR42","doi-asserted-by":"publisher","first-page":"879575","DOI":"10.3389\/fimmu.2022.879575","volume":"13","author":"F Zhu","year":"2022","unstructured":"Zhu F, et al. H1N1 influenza virus-infected nasal mucosal epithelial progenitor cells promote dendritic cell recruitment and maturation. Front Immunol. 2022;13:879575. https:\/\/doi.org\/10.3389\/fimmu.2022.879575.","journal-title":"Front Immunol"},{"issue":"3","key":"2110_CR43","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/alr.23482","volume":"15","author":"NS Khan","year":"2025","unstructured":"Khan NS, et al. Viral infection as an inciting event for development of chronic rhinosinusitis: a population-based study. Int Forum Allergy Rhinol. 2025;15(3):336\u20139. https:\/\/doi.org\/10.1002\/alr.23482.","journal-title":"Int Forum Allergy Rhinol"},{"issue":"1","key":"2110_CR44","doi-asserted-by":"publisher","first-page":"8416","DOI":"10.1038\/s41467-024-51995-2","volume":"15","author":"I Godet","year":"2024","unstructured":"Godet I, et al. Hypoxia induces ROS-resistant memory upon reoxygenation in vivo promoting metastasis in part via MUC1-C. Nat Commun. 2024;15(1):8416. https:\/\/doi.org\/10.1038\/s41467-024-51995-2.","journal-title":"Nat Commun"},{"key":"2110_CR45","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.freeradbiomed.2024.10.304","volume":"225","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, et al. Influenza A virus-induced glycolysis facilitates virus replication by activating ROS\/HIF-1\u03b1 pathway. Free Radic Biol Med. 2024;225:910\u201324. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2024.10.304.","journal-title":"Free Radic Biol Med"},{"key":"2110_CR46","doi-asserted-by":"publisher","first-page":"155446","DOI":"10.1016\/j.phymed.2024.155446","volume":"128","author":"D Deng","year":"2024","unstructured":"Deng D, et al. Xijiao dihuang decoction combined with Yinqiao powder promotes autophagy-dependent ROS decrease to inhibit ROS\/NLRP3\/pyroptosis regulation axis in influenza virus infection. Phytomedicine. 2024;128:155446. https:\/\/doi.org\/10.1016\/j.phymed.2024.155446.","journal-title":"Phytomedicine"},{"issue":"1","key":"2110_CR47","doi-asserted-by":"publisher","first-page":"2458942","DOI":"10.1080\/13510002.2025.2458942","volume":"30","author":"L Meng","year":"2025","unstructured":"Meng L, et al. Oxidative stress and reactive oxygen species in otorhinolaryngological diseases: insights from pathophysiology to targeted antioxidant therapies. Redox Rep. 2025;30(1):2458942. https:\/\/doi.org\/10.1080\/13510002.2025.2458942.","journal-title":"Redox Rep"},{"issue":"1","key":"2110_CR48","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13020-024-00897-y","volume":"19","author":"R Wang","year":"2024","unstructured":"Wang R, et al. Platycodon D protects human nasal epithelial cells from pyroptosis through the Nrf2\/HO-1\/ROS signaling cascade in chronic rhinosinusitis. Chin Med. 2024;19(1):40. https:\/\/doi.org\/10.1186\/s13020-024-00897-y.","journal-title":"Chin Med"},{"issue":"2","key":"2110_CR49","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41590-017-0013-y","volume":"19","author":"C Holze","year":"2018","unstructured":"Holze C, et al. Oxeiptosis, a ROS-induced caspase-independent apoptosis-like cell-death pathway. Nat Immunol. 2018;19(2):130\u201340. https:\/\/doi.org\/10.1038\/s41590-017-0013-y.","journal-title":"Nat Immunol"},{"key":"2110_CR50","doi-asserted-by":"publisher","first-page":"106438","DOI":"10.1016\/j.intimp.2020.106438","volume":"83","author":"YM Wang","year":"2020","unstructured":"Wang YM, et al. Protective and predictive role of Mucin1 in sepsis-induced ALI\/ARDS. Int Immunopharmacol. 2020;83:106438. https:\/\/doi.org\/10.1016\/j.intimp.2020.106438.","journal-title":"Int Immunopharmacol"},{"key":"2110_CR51","doi-asserted-by":"publisher","first-page":"111675","DOI":"10.1016\/j.colsurfb.2021.111675","volume":"202","author":"S Feizi","year":"2021","unstructured":"Feizi S, et al. Colloidal silver combating pathogenic Pseudomonas aeruginosa and MRSA in chronic rhinosinusitis. Colloids Surf B Biointerfaces. 2021;202:111675. https:\/\/doi.org\/10.1016\/j.colsurfb.2021.111675.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"1","key":"2110_CR52","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1186\/s12964-023-01347-2","volume":"21","author":"Z Chegini","year":"2023","unstructured":"Chegini Z, et al. The destruction of mucosal barriers, epithelial remodeling, and impaired mucociliary clearance: possible pathogenic mechanisms of Pseudomonas aeruginosa and Staphylococcus aureus in chronic rhinosinusitis. Cell Commun Signal. 2023;21(1):306. https:\/\/doi.org\/10.1186\/s12964-023-01347-2.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"2110_CR53","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11882-015-0583-4","volume":"16","author":"K Scheckenbach","year":"2016","unstructured":"Scheckenbach K, Wagenmann M. Cytokine patterns and endotypes in acute and chronic rhinosinusitis. Curr Allergy Asthma Rep. 2016;16(1):3. https:\/\/doi.org\/10.1007\/s11882-015-0583-4.","journal-title":"Curr Allergy Asthma Rep"},{"key":"2110_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8091447","author":"B Ballester","year":"2019","unstructured":"Ballester B, Milara J, Cortijo J. Mucins as a new frontier in pulmonary fibrosis. J Clin Med. 2019. https:\/\/doi.org\/10.3390\/jcm8091447.","journal-title":"J Clin Med"},{"issue":"3","key":"2110_CR55","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.jaci.2024.04.019","volume":"154","author":"C Liu","year":"2024","unstructured":"Liu C, et al. Alox15+ M2 macrophages contribute to epithelial remodeling in eosinophilic chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2024;154(3):592\u2013608. https:\/\/doi.org\/10.1016\/j.jaci.2024.04.019.","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"2110_CR56","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1158\/1541-7786.Mcr-16-0233","volume":"14","author":"M Alam","year":"2016","unstructured":"Alam M, et al. MUC1-C represses the Crumbs complex polarity factor CRB3 and downregulates the Hippo pathway. Mol Cancer Res. 2016;14(12):1266\u201376. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-16-0233.","journal-title":"Mol Cancer Res"},{"issue":"8","key":"2110_CR57","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1111\/all.16182","volume":"79","author":"E Nikolouli","year":"2024","unstructured":"Nikolouli E, et al. The stimulation of TH2 cells results in increased IL-5 and IL-13 production via the H(4) receptor. Allergy. 2024;79(8):2186\u201396. https:\/\/doi.org\/10.1111\/all.16182.","journal-title":"Allergy"},{"key":"2110_CR58","doi-asserted-by":"publisher","first-page":"1285598","DOI":"10.3389\/fimmu.2024.1285598","volume":"15","author":"S AlBloushi","year":"2024","unstructured":"AlBloushi S, Al-Ahmad M. Exploring the immunopathology of type 2 inflammatory airway diseases. Front Immunol. 2024;15:1285598. https:\/\/doi.org\/10.3389\/fimmu.2024.1285598.","journal-title":"Front Immunol"},{"issue":"3","key":"2110_CR59","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41423-025-01261-2","volume":"22","author":"I Ogulur","year":"2025","unstructured":"Ogulur I, et al. Type 2 immunity in allergic diseases. Cell Mol Immunol. 2025;22(3):211\u201342. https:\/\/doi.org\/10.1038\/s41423-025-01261-2.","journal-title":"Cell Mol Immunol"},{"key":"2110_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/cells14010033","author":"Y Kobayashi","year":"2024","unstructured":"Kobayashi Y, et al. Ccl4 affects eosinophil survival via the shedding of the MUC1 n-terminal domain in airway inflammation. Cells. 2024. https:\/\/doi.org\/10.3390\/cells14010033.","journal-title":"Cells"},{"key":"2110_CR61","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.molimm.2023.03.004","volume":"156","author":"L Tang","year":"2023","unstructured":"Tang L, et al. BMAL1 regulates MUC1 overexpression in ovalbumin-induced asthma. Mol Immunol. 2023;156:77\u201384. https:\/\/doi.org\/10.1016\/j.molimm.2023.03.004.","journal-title":"Mol Immunol"},{"issue":"1","key":"2110_CR62","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s12931-023-02620-1","volume":"24","author":"A Akenroye","year":"2023","unstructured":"Akenroye A, et al. Lower myostatin and higher MUC1 levels are associated with better response to mepolizumab and omalizumab in asthma: a protein-protein interaction analyses. Respir Res. 2023;24(1):305. https:\/\/doi.org\/10.1186\/s12931-023-02620-1.","journal-title":"Respir Res"},{"issue":"5","key":"2110_CR63","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s40264-020-00926-3","volume":"43","author":"DJ Jackson","year":"2020","unstructured":"Jackson DJ, et al. Safety of eosinophil-depleting therapy for severe, eosinophilic asthma: focus on benralizumab. Drug Saf. 2020;43(5):409\u201325. https:\/\/doi.org\/10.1007\/s40264-020-00926-3.","journal-title":"Drug Saf"},{"key":"2110_CR64","doi-asserted-by":"publisher","first-page":"110228","DOI":"10.1016\/j.clim.2024.110228","volume":"263","author":"L Xu","year":"2024","unstructured":"Xu L, et al. Eosinophil peroxidase promotes bronchial epithelial cells to secrete asthma-related factors and induces the early stage of airway remodeling. Clin Immunol. 2024;263:110228. https:\/\/doi.org\/10.1016\/j.clim.2024.110228.","journal-title":"Clin Immunol"},{"issue":"3","key":"2110_CR65","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.2353\/ajpath.2010.091129","volume":"177","author":"YT Chen","year":"2010","unstructured":"Chen YT, et al. Cigarette smoke induces epidermal growth factor receptor-dependent redistribution of apical MUC1 and junctional beta-catenin in polarized human airway epithelial cells. Am J Pathol. 2010;177(3):1255\u201364. https:\/\/doi.org\/10.2353\/ajpath.2010.091129.","journal-title":"Am J Pathol"},{"issue":"5","key":"2110_CR66","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1038\/s41385-021-00415-5","volume":"14","author":"N Oikonomou","year":"2021","unstructured":"Oikonomou N, et al. Airway epithelial cell necroptosis contributes to asthma exacerbation in a mouse model of house dust mite-induced allergic inflammation. Mucosal Immunol. 2021;14(5):1160\u201371. https:\/\/doi.org\/10.1038\/s41385-021-00415-5.","journal-title":"Mucosal Immunol"},{"key":"2110_CR67","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.lfs.2019.02.013","volume":"221","author":"H Zhang","year":"2019","unstructured":"Zhang H, et al. Mucin 1 downregulation impairs the anti-necroptotic effects of glucocorticoids in human bronchial epithelial cells. Life Sci. 2019;221:168\u201377. https:\/\/doi.org\/10.1016\/j.lfs.2019.02.013.","journal-title":"Life Sci"},{"key":"2110_CR68","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25136913","author":"LL Kan","year":"2024","unstructured":"Kan LL, et al. Deciphering the interplay between the epithelial barrier, immune cells, and metabolic mediators in allergic disease. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25136913.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2110_CR69","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1177\/19458924231193154","volume":"37","author":"HW Yu","year":"2023","unstructured":"Yu HW, et al. Tslp induces epithelial-mesenchymal transition in nasal epithelial cells from allergic rhinitis patients through TGF-\u03b21\/Smad2\/3 signaling. Am J Rhinol Allergy. 2023;37(6):739\u201350. https:\/\/doi.org\/10.1177\/19458924231193154.","journal-title":"Am J Rhinol Allergy"},{"issue":"3","key":"2110_CR70","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/alr.22243","volume":"9","author":"B Yan","year":"2019","unstructured":"Yan B, et al. Inhibition of arachidonate 15-lipoxygenase reduces the epithelial-mesenchymal transition in eosinophilic chronic rhinosinusitis with nasal polyps. Int Forum Allergy Rhinol. 2019;9(3):270\u201380. https:\/\/doi.org\/10.1002\/alr.22243.","journal-title":"Int Forum Allergy Rhinol"},{"issue":"6","key":"2110_CR71","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1016\/j.jaci.2019.07.042","volume":"144","author":"LB Zhou","year":"2019","unstructured":"Zhou LB, et al. MUC1 deficiency promotes nasal epithelial barrier dysfunction in subjects with allergic rhinitis. J Allergy Clin Immunol. 2019;144(6):1716-1719.e5. https:\/\/doi.org\/10.1016\/j.jaci.2019.07.042.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"2110_CR72","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1111\/all.15235","volume":"77","author":"C Zhang","year":"2022","unstructured":"Zhang C, et al. MUC1 deficiency induces the nasal epithelial barrier dysfunction via RBFOX3 shortage augment ubiquitin-proteasomal degradation in allergic rhinitis pathogenesis. Allergy. 2022;77(5):1596\u20139. https:\/\/doi.org\/10.1111\/all.15235.","journal-title":"Allergy"},{"issue":"2","key":"2110_CR73","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.alit.2020.02.002","volume":"69","author":"H Nagase","year":"2020","unstructured":"Nagase H, Ueki S, Fujieda S. The roles of IL-5 and anti-IL-5 treatment in eosinophilic diseases: Asthma, eosinophilic granulomatosis with polyangiitis, and eosinophilic chronic rhinosinusitis. Allergol Int. 2020;69(2):178\u201386. https:\/\/doi.org\/10.1016\/j.alit.2020.02.002.","journal-title":"Allergol Int"},{"issue":"4","key":"2110_CR74","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.mucimm.2024.03.005","volume":"17","author":"J Luo","year":"2024","unstructured":"Luo J, et al. IL-5 antagonism reverses priming and activation of eosinophils in severe eosinophilic asthma. Mucosal Immunol. 2024;17(4):524\u201336. https:\/\/doi.org\/10.1016\/j.mucimm.2024.03.005.","journal-title":"Mucosal Immunol"},{"issue":"9","key":"2110_CR75","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1016\/j.jaip.2023.05.011","volume":"11","author":"C Bachert","year":"2023","unstructured":"Bachert C, et al. The unified airway hypothesis: evidence from specific intervention with anti-IL-5 biologic therapy. J Allergy Clin Immunol Pract. 2023;11(9):2630\u201341. https:\/\/doi.org\/10.1016\/j.jaip.2023.05.011.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"2110_CR76","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.jaci.2021.08.030","volume":"149","author":"C Bachert","year":"2022","unstructured":"Bachert C, et al. Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: a randomized, placebo-controlled trial. J Allergy Clin Immunol. 2022;149(4):1309-1317.e12. https:\/\/doi.org\/10.1016\/j.jaci.2021.08.030.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"2110_CR77","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.jaci.2014.07.011","volume":"135","author":"J Milara","year":"2015","unstructured":"Milara J, et al. Mucin 1 downregulation associates with corticosteroid resistance in chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2015;135(2):470\u20136. https:\/\/doi.org\/10.1016\/j.jaci.2014.07.011.","journal-title":"J Allergy Clin Immunol"},{"key":"2110_CR78","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21051837","author":"I Janulaityte","year":"2020","unstructured":"Janulaityte I, et al. In vivo allergen-activated eosinophils promote collagen I and fibronectin gene expression in airway smooth muscle cells via TGF-\u03b21 signaling pathway in asthma. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21051837.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2110_CR79","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1136\/thoraxjnl-2018-212735","volume":"75","author":"J Milara","year":"2020","unstructured":"Milara J, et al. MUC1 intracellular bioactivation mediates lung fibrosis. Thorax. 2020;75(2):132\u201342. https:\/\/doi.org\/10.1136\/thoraxjnl-2018-212735.","journal-title":"Thorax"},{"issue":"4","key":"2110_CR80","doi-asserted-by":"publisher","first-page":"338","DOI":"10.4193\/Rhin22.439","volume":"61","author":"S Jo","year":"2023","unstructured":"Jo S, et al. Eosinophil-derived TGF\u03b21 controls the new bone formation in chronic rhinosinusitis with nasal polyps. Rhinology. 2023;61(4):338\u201347. https:\/\/doi.org\/10.4193\/Rhin22.439.","journal-title":"Rhinology"},{"issue":"2","key":"2110_CR81","doi-asserted-by":"publisher","first-page":"L355","DOI":"10.1152\/ajplung.00040.2005","volume":"289","author":"I Kuwahara","year":"2005","unstructured":"Kuwahara I, et al. Neutrophil elastase stimulates MUC1 gene expression through increased Sp1 binding to the MUC1 promoter. Am J Physiol Lung Cell Mol Physiol. 2005;289(2):L355\u201362. https:\/\/doi.org\/10.1152\/ajplung.00040.2005.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"2110_CR82","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12931-018-0927-4","volume":"19","author":"J Milara","year":"2018","unstructured":"Milara J, et al. MUC1 deficiency mediates corticosteroid resistance in chronic obstructive pulmonary disease. Respir Res. 2018;19(1):226. https:\/\/doi.org\/10.1186\/s12931-018-0927-4.","journal-title":"Respir Res"},{"issue":"10","key":"2110_CR83","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1164\/rccm.202210-1865OC","volume":"208","author":"I Sulaiman","year":"2023","unstructured":"Sulaiman I, et al. Lower airway dysbiosis augments lung inflammatory injury in mild-to-moderate chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2023;208(10):1101\u201314. https:\/\/doi.org\/10.1164\/rccm.202210-1865OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"2110_CR84","doi-asserted-by":"publisher","first-page":"16031","DOI":"10.1038\/nmicrobiol.2016.31","volume":"1","author":"LN Segal","year":"2016","unstructured":"Segal LN, et al. Enrichment of the lung microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype. Nat Microbiol. 2016;1:16031. https:\/\/doi.org\/10.1038\/nmicrobiol.2016.31.","journal-title":"Nat Microbiol"},{"issue":"1","key":"2110_CR85","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.alit.2016.04.017","volume":"66","author":"Y Noyama","year":"2017","unstructured":"Noyama Y, et al. IL-22\/IL-22R1 signaling regulates the pathophysiology of chronic rhinosinusitis with nasal polyps via alteration of MUC1 expression. Allergol Int. 2017;66(1):42\u201351. https:\/\/doi.org\/10.1016\/j.alit.2016.04.017.","journal-title":"Allergol Int"},{"issue":"4","key":"2110_CR86","doi-asserted-by":"publisher","first-page":"437","DOI":"10.4168\/aair.2023.15.4.437","volume":"15","author":"JY Min","year":"2023","unstructured":"Min JY, et al. Inflammatory endotypes of chronic rhinosinusitis in the Korean population: distinct expression of type 3 inflammation. Allergy Asthma Immunol Res. 2023;15(4):437\u201350. https:\/\/doi.org\/10.4168\/aair.2023.15.4.437.","journal-title":"Allergy Asthma Immunol Res"},{"issue":"2","key":"2110_CR87","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jaci.2022.02.031","volume":"150","author":"Y Li","year":"2022","unstructured":"Li Y, et al. Il-17a mediates pyroptosis via the ERK pathway and contributes to steroid resistance in CRSwNP. J Allergy Clin Immunol. 2022;150(2):337\u201351. https:\/\/doi.org\/10.1016\/j.jaci.2022.02.031.","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"2110_CR88","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1016\/j.jaip.2019.05.009","volume":"7","author":"WW Stevens","year":"2019","unstructured":"Stevens WW, et al. Associations between inflammatory endotypes and clinical presentations in chronic rhinosinusitis. J Allergy Clin Immunol Pract. 2019;7(8):2812-2820.e3. https:\/\/doi.org\/10.1016\/j.jaip.2019.05.009.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"18","key":"2110_CR89","doi-asserted-by":"publisher","first-page":"7506","DOI":"10.1073\/pnas.0611589104","volume":"104","author":"A Maitra","year":"2007","unstructured":"Maitra A, et al. Distinct functional motifs within the IL-17 receptor regulate signal transduction and target gene expression. Proc Natl Acad Sci USA. 2007;104(18):7506\u201311. https:\/\/doi.org\/10.1073\/pnas.0611589104.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2110_CR90","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.cytogfr.2016.03.009","volume":"30","author":"NI Lor\u00e8","year":"2016","unstructured":"Lor\u00e8 NI, Bragonzi A, Cigana C. The IL-17A\/IL-17RA axis in pulmonary defence and immunopathology. Cytokine Growth Factor Rev. 2016;30:19\u201327. https:\/\/doi.org\/10.1016\/j.cytogfr.2016.03.009.","journal-title":"Cytokine Growth Factor Rev"},{"key":"2110_CR91","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25158223","author":"M G\u00f3mez-Garc\u00eda","year":"2024","unstructured":"G\u00f3mez-Garc\u00eda M, et al. The role of the gut and airway microbiota in chronic rhinosinusitis with nasal polyps: a systematic review. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25158223.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"2110_CR92","doi-asserted-by":"publisher","first-page":"3082","DOI":"10.1111\/all.16240","volume":"79","author":"JT Connell","year":"2024","unstructured":"Connell JT, et al. Characterising the allergic fungal rhinosinusitis microenvironment using full-length 16S rRNA gene amplicon sequencing and fungal ITS sequencing. Allergy. 2024;79(11):3082\u201394. https:\/\/doi.org\/10.1111\/all.16240.","journal-title":"Allergy"},{"issue":"2","key":"2110_CR93","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/all.15168","volume":"77","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, et al. Predicting the recurrence of chronic rhinosinusitis with nasal polyps using nasal microbiota. Allergy. 2022;77(2):540\u20139. https:\/\/doi.org\/10.1111\/all.15168.","journal-title":"Allergy"},{"issue":"1","key":"2110_CR94","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1172\/jci121087","volume":"129","author":"SA Christenson","year":"2019","unstructured":"Christenson SA, et al. An airway epithelial IL-17A response signature identifies a steroid-unresponsive COPD patient subgroup. J Clin Invest. 2019;129(1):169\u201381. https:\/\/doi.org\/10.1172\/jci121087.","journal-title":"J Clin Invest"},{"issue":"2","key":"2110_CR95","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.jaci.2021.12.769","volume":"149","author":"Y Xie","year":"2022","unstructured":"Xie Y, et al. T(H)17 cells and corticosteroid insensitivity in severe asthma. J Allergy Clin Immunol. 2022;149(2):467\u201379. https:\/\/doi.org\/10.1016\/j.jaci.2021.12.769.","journal-title":"J Allergy Clin Immunol"},{"key":"2110_CR96","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.132836","author":"S Ouyang","year":"2020","unstructured":"Ouyang S, et al. Targeting IL-17A\/glucocorticoid synergy to CSF3 expression in neutrophilic airway diseases. JCI Insight. 2020. https:\/\/doi.org\/10.1172\/jci.insight.132836.","journal-title":"JCI Insight"},{"issue":"5","key":"2110_CR97","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.jaci.2014.05.038","volume":"134","author":"C Irvin","year":"2014","unstructured":"Irvin C, et al. Increased frequency of dual-positive TH2\/TH17 cells in bronchoalveolar lavage fluid characterizes a population of patients with severe asthma. J Allergy Clin Immunol. 2014;134(5):1175-1186.e7. https:\/\/doi.org\/10.1016\/j.jaci.2014.05.038.","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"2110_CR98","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1111\/all.14526","volume":"75","author":"H Hong","year":"2020","unstructured":"Hong H, et al. Role of IL-25, IL-33, and TSLP in triggering united airway diseases toward type 2 inflammation. Allergy. 2020;75(11):2794\u2013804. https:\/\/doi.org\/10.1111\/all.14526.","journal-title":"Allergy"},{"issue":"7","key":"2110_CR99","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.21037\/jtd.2017.06.63","volume":"9","author":"Z Zheng","year":"2017","unstructured":"Zheng Z, et al. Sputum mucin 1 is increased during the acute phase of chronic obstructive pulmonary disease exacerbation. J Thorac Dis. 2017;9(7):1873\u201382. https:\/\/doi.org\/10.21037\/jtd.2017.06.63.","journal-title":"J Thorac Dis"},{"issue":"1","key":"2110_CR100","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/s41598-019-57108-0","volume":"10","author":"W Bertrams","year":"2020","unstructured":"Bertrams W, et al. Transcriptional analysis identifies potential biomarkers and molecular regulators in pneumonia and COPD exacerbation. Sci Rep. 2020;10(1):241. https:\/\/doi.org\/10.1038\/s41598-019-57108-0.","journal-title":"Sci Rep"},{"issue":"10","key":"2110_CR101","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1159\/000508936","volume":"181","author":"L Bergantini","year":"2020","unstructured":"Bergantini L, et al. Personalized approach of severe eosinophilic asthma patients treated with mepolizumab and benralizumab. Int Arch Allergy Immunol. 2020;181(10):746\u201353. https:\/\/doi.org\/10.1159\/000508936.","journal-title":"Int Arch Allergy Immunol"},{"issue":"4","key":"2110_CR102","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1002\/alr.23274","volume":"14","author":"H Zeng","year":"2024","unstructured":"Zeng H, et al. The Olink proteomics profile in nasal secretion of patients with allergic rhinitis. Int Forum Allergy Rhinol. 2024;14(4):862\u20135. https:\/\/doi.org\/10.1002\/alr.23274.","journal-title":"Int Forum Allergy Rhinol"},{"issue":"12","key":"2110_CR103","doi-asserted-by":"publisher","first-page":"5133","DOI":"10.1158\/0008-5472.Can-09-0854","volume":"69","author":"D Raina","year":"2009","unstructured":"Raina D, et al. Direct targeting of the mucin 1 oncoprotein blocks survival and tumorigenicity of human breast carcinoma cells. Cancer Res. 2009;69(12):5133\u201341. https:\/\/doi.org\/10.1158\/0008-5472.Can-09-0854.","journal-title":"Cancer Res"},{"issue":"10","key":"2110_CR104","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1158\/1078-0432.Ccr-14-3000","volume":"21","author":"M Hasegawa","year":"2015","unstructured":"Hasegawa M, et al. Intracellular targeting of the oncogenic MUC1-C protein with a novel GO-203 nanoparticle formulation. Clin Cancer Res. 2015;21(10):2338\u201347. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-14-3000.","journal-title":"Clin Cancer Res"},{"key":"2110_CR105","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ejca.2016.05.003","volume":"63","author":"W Fiedler","year":"2016","unstructured":"Fiedler W, et al. A phase I study of PankoMab-GEX, a humanised glyco-optimised monoclonal antibody to a novel tumour-specific MUC1 glycopeptide epitope in patients with advanced carcinomas. Eur J Cancer. 2016;63:55\u201363. https:\/\/doi.org\/10.1016\/j.ejca.2016.05.003.","journal-title":"Eur J Cancer"},{"issue":"1","key":"2110_CR106","doi-asserted-by":"publisher","first-page":"100311","DOI":"10.1016\/j.esmoop.2021.100311","volume":"7","author":"JA Ledermann","year":"2022","unstructured":"Ledermann JA, et al. Maintenance therapy of patients with recurrent epithelial ovarian carcinoma with the anti-tumor-associated-mucin-1 antibody gatipotuzumab: results from a double-blind, placebo-controlled, randomized, phase II study. ESMO Open. 2022;7(1):100311. https:\/\/doi.org\/10.1016\/j.esmoop.2021.100311.","journal-title":"ESMO Open"},{"issue":"5","key":"2110_CR107","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.ijrobp.2020.06.069","volume":"108","author":"A Detappe","year":"2020","unstructured":"Detappe A, et al. Anti-MUC1-C antibody-conjugated nanoparticles potentiate the efficacy of fractionated radiation therapy. Int J Radiat Oncol Biol Phys. 2020;108(5):1380\u20139. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.06.069.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2110_CR108","doi-asserted-by":"publisher","first-page":"628776","DOI":"10.3389\/fimmu.2020.628776","volume":"11","author":"R Zhou","year":"2020","unstructured":"Zhou R, et al. Corrigendum: CAR t cells targeting the tumor MUC1 glycoprotein reduce triple-negative breast cancer growth. Front Immunol. 2020;11:628776. https:\/\/doi.org\/10.3389\/fimmu.2020.628776.","journal-title":"Front Immunol"},{"issue":"1","key":"2110_CR109","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-017-0274-x","volume":"5","author":"C Tosch","year":"2017","unstructured":"Tosch C, et al. Viral based vaccine TG4010 induces broadening of specific immune response and improves outcome in advanced NSCLC. J Immunother Cancer. 2017;5(1):70. https:\/\/doi.org\/10.1186\/s40425-017-0274-x.","journal-title":"J Immunother Cancer"},{"issue":"2","key":"2110_CR110","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/s1470-2045(15)00483-0","volume":"17","author":"E Quoix","year":"2016","unstructured":"Quoix E, et al. TG4010 immunotherapy and first-line chemotherapy for advanced non-small-cell lung cancer (TIME): results from the phase 2b part of a randomised, double-blind, placebo-controlled, phase 2b\/3 trial. Lancet Oncol. 2016;17(2):212\u201323. https:\/\/doi.org\/10.1016\/s1470-2045(15)00483-0.","journal-title":"Lancet Oncol"},{"issue":"1","key":"2110_CR111","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/s1470-2045(13)70510-2","volume":"15","author":"C Butts","year":"2014","unstructured":"Butts C, et al. Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial. Lancet Oncol. 2014;15(1):59\u201368. https:\/\/doi.org\/10.1016\/s1470-2045(13)70510-2.","journal-title":"Lancet Oncol"},{"key":"2110_CR112","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ejca.2020.03.018","volume":"132","author":"CF Singer","year":"2020","unstructured":"Singer CF, et al. Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: results from a prospective, randomised, neoadjuvant phase II study (ABCSG 34). Eur J Cancer. 2020;132:43\u201352. https:\/\/doi.org\/10.1016\/j.ejca.2020.03.018.","journal-title":"Eur J Cancer"},{"issue":"3","key":"2110_CR113","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/cas.13144","volume":"108","author":"J Wang","year":"2017","unstructured":"Wang J, et al. Targeting MUC1 and JNK by RNA interference and inhibitor inhibit the development of hepatocellular carcinoma. Cancer Sci. 2017;108(3):504\u201311. https:\/\/doi.org\/10.1111\/cas.13144.","journal-title":"Cancer Sci"},{"issue":"1","key":"2110_CR114","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s12951-022-01478-7","volume":"20","author":"SH Kiaie","year":"2022","unstructured":"Kiaie SH, et al. Recent advances in mRNA-LNP therapeutics: immunological and pharmacological aspects. J Nanobiotechnology. 2022;20(1):276. https:\/\/doi.org\/10.1186\/s12951-022-01478-7.","journal-title":"J Nanobiotechnology"},{"key":"2110_CR115","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2024.5384","author":"Q Liu","year":"2024","unstructured":"Liu Q, et al. Paeoniflorigenone inhibits ovarian cancer metastasis through targeting the MUC1\/Wnt\/\u03b2-catenin pathway. Int J Mol Med. 2024. https:\/\/doi.org\/10.3892\/ijmm.2024.5384.","journal-title":"Int J Mol Med"},{"issue":"1","key":"2110_CR116","doi-asserted-by":"publisher","first-page":"C59","DOI":"10.1152\/ajpcell.00070.2013","volume":"306","author":"K Zhang","year":"2014","unstructured":"Zhang K, et al. Tanshinone IIA inhibits lipopolysaccharide-induced MUC1 overexpression in alveolar epithelial cells. Am J Physiol Cell Physiol. 2014;306(1):C59-65. https:\/\/doi.org\/10.1152\/ajpcell.00070.2013.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"6","key":"2110_CR117","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.chom.2023.04.018","volume":"31","author":"W Liang","year":"2023","unstructured":"Liang W, et al. Airway dysbiosis accelerates lung function decline in chronic obstructive pulmonary disease. Cell Host Microbe. 2023;31(6):1054\u201370. https:\/\/doi.org\/10.1016\/j.chom.2023.04.018.","journal-title":"Cell Host Microbe"},{"key":"2110_CR118","doi-asserted-by":"publisher","first-page":"1079154","DOI":"10.3389\/fimmu.2023.1079154","volume":"14","author":"Y Wang","year":"2023","unstructured":"Wang Y, et al. Characterization of dysbiosis of the conjunctival microbiome and nasal microbiome associated with allergic rhinoconjunctivitis and allergic rhinitis. Front Immunol. 2023;14:1079154. https:\/\/doi.org\/10.3389\/fimmu.2023.1079154.","journal-title":"Front Immunol"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-025-02110-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-025-02110-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-025-02110-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T16:53:34Z","timestamp":1767200014000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-025-02110-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":118,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2110"],"URL":"https:\/\/doi.org\/10.1007\/s00011-025-02110-8","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"11 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised due to correction on affiliation 3.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"143"}}